SLRN ACELYRIN Inc. Gross Profitability

Official company branding of ACELYRIN, Inc. (SLRN)

Acelyrin, Inc. (SLRN) is attracting top immunologists by offering generous stock options to develop breakthrough antibodies. The gross margin history on the GURU.Markets daily chart reflects profit dynamics, where 0.00 is recorded as the baseline value. However, Acelyrin, Inc. (SLRN) faces high costs and competition, while a heavy reliance on a single drug creates significant binary risks for investors.

Gross Profitability: acelyrin.com (SLRN) for 02/21/2024 - 05/31/2025

Analytical breakdowns and data insights for company ACELYRIN (SLRN)

- stock value and consensus price forecast:
Summary company analysis:ACELYRIN (SLRN)
Mass-produced product of acelyrin.com

Investors are verifying the issuer's stability by analyzing cost management efficiency. The annual gross margin on GURU.Markets reflects the profit share after deducting direct production costs, signaling the business's ability to scale without sacrificing profitability. For Acelyrin, Inc. (SLRN), this indicator will become critical during the market launch of isokibep, confirming the therapy's pricing power relative to existing biologics.

Direct competitors

Gross Profit Margin Haleon PLC (HLN)|Return on Gross Profit KVUE|Gross Profit Margin Verona Pharma Inc. VRNA|Gross Margin MENS|Ligand Pharmaceuticals - Gross Return on Sales|Gross Profitability Amneal AMRX|Gross Sales Margin Perrigo Company PLC|Alvotech Biopharmaceuticals - Gross Margin|Return on Sales by Gross Profit Liquidia Technologies LQDA|Galapagos N.V. (GLPG) - Gross Profitability|anipharmaceuticals.com - Gross Profit Rate|Return on Gross Profit MNKD|AMPH: Gross Profit Rate|Gross Profitability pacira.com (PCRX)|Gross Margin ARS Pharma (SPRY)|Theravance Biopharma - Return on Gross Profit|Gross Profit Ratio AQST (Aquestive Therapeutics)|SCPH: Return on Gross Profit|Gross Profit Margin Tectonic Therapeutic|TNXP: Gross Margin|SXT China (SXTC) - Gross Margin|Gross Profitability eupraxiapharma.com|BioHarvest Sciences (BHST) - Return on Sales by Gross Profit|Gross Profitability Invizyne (EXOZ)|ORMP - Gross Profit Margin|Gross Margin ENTX (Entera Bio)|Gross Sales Margin MindWalk Therapeutics|ABVC: Return on Gross Profit|CPIX - Gross Margin|QNTM (Quantum BioPharma) - Return on Gross Profit|Gross Profitability Margin FGEN (FibroGen)|TELO (Telomir Pharmaceuticals Corp) - Gross Margin|Gross Margin ranitherapeutics.com|Gross Profitability Synergy CHC Corp. (SNYR)|Rallybio Corp - Gross Return on Sales|lexariabioscience.com - Return on Gross Profit|Gross Margin Pulmatrix Inc PULM|Pheton Holdings - Gross Margin|Gross Profitability Margin APM|Lyra Therapeutics, Inc. (LYRA) - Gross Profitability|Gross Profit Margin Impact BioMedical, Inc. (IBO)|Gross Profitability TNF Pharma|YCBD: Gross Profit Rate|Gross Margin PRFX|CYTO - Gross Profit Margin|Gross Profitability Lipella LIPO|Gross Profit Ratio OPTN (OptiNose, Inc.)|PIRS - Gross Profitability|Procaps (PROC) - Return on Gross Profit|PTPI: Gross Margin|Qilian International (QLI) - Gross Margin|TFFP (TFF Pharmaceuticals, Inc) - Gross Margin